GlassScriptPhysician profile
Jeffrey Leo Congeni
NPI 1730126749
$1,607.50
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $96.56 · 2021: $585 · 2022: $249 · 2023: $140 · 2024: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397 · Entertainment: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.81 |
| Entertainment | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $284.91 | 2019-2021 | |
| New World Medical,INC. | $269.33 | 2021-2023 | |
| Biotissue Holdings INC. | $142.96 | 2021-2024 | |
| Johnson & Johnson Surgical Vision, INC. | $140.53 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $125.44 | 2021-2023 | Acthar |
| Rayner Intraocular Lenses Limited | $114.88 | 2022-2024 | Omidria, Rayone Spheric, Rayone Emv |
| Ocular Therapeutix, INC. | $97.22 | 2020-2023 | Dextenza |
| Allergan, INC. | $90.58 | 2019-2022 | |
| Abbvie INC. | $75.59 | 2024 | |
| Novartis Pharmaceuticals Corporation | $61.66 | 2019-2021 | |
| Alcon Vision LLC | $49.22 | 2020-2022 | |
| Shire North American Group INC | $21.72 | 2019 | |
| Aerie Pharmaceuticals, INC. | $18.74 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $18.28 | 2024 | Xdemvy |
| Rxsight INC | $18.18 | 2023 | Rxsight Injector Handpiece, Rxsight Light Adjustable Lens (Rxlal), Rxsight Light Delivery Device (Ldd) |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $15.00 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Tearlab Corp | $14.10 | 2021 | |
| Omeros Corporation | $13.50 | 2021 | |
| Dompe US, INC. | $12.93 | 2021 | |
| Sun Pharmaceutical Industries INC. | $11.48 | 2019 | |
| Kala Pharmaceuticals, INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Congeni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.